Monitoring the therapy of pulmonary tuberculosis by nested polymerase chain reaction assay

Journal of Infection

Volumn 34, Issue 1, 1997, Pages 29-33

  Yuen, K Y ^a   Chan, K S ^b   Chan, C M ^a   Ho, P L ^a   Ng, M H ^a  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

^b Haven of Hope Hospital   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

TUBERCULOSTATIC AGENT;

ARTICLE; HUMAN; LUNG TUBERCULOSIS; MAJOR CLINICAL STUDY; MONITORING; MYCOBACTERIUM TUBERCULOSIS; POLYMERASE CHAIN REACTION; RELAPSE;

EID: 0031053260     PISSN: 01634453     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0163-4453(97)80006-0     Document Type: Article

References (15)

1. Bloom BR, Murray CJL. Tuberculosis: Commentary on a reemergent killer. Science 1992; 257: 1055-1064.
2. Clarridge III JE, Shawar RM, Shinnick TM, Plikaytis BB. Large-scale use of polymerase chain reaction for detection of Mycobacterium tuberculosis in a routine mycobacteriology laboratory. J Clin Microbiol 1993; 31: 2049-2056.
3. Brisson-Noel A, Aznar C, Chureau C et al. Diagnosis of tuberculosis by DNA amplification in clinical practice evaluation. J Clin Microbiol 1991; 338: 364-366.
4. Kennedy N, Gillespie SH, Saruni AOS et al. Polymerase chain reaction for assessing treatment response in patients with pulmonary tuberculosis. J Infect Dis 1994; 170: 713-716.
5. Levée G, Glaziou P, Gicquel B, Chanteau S. Follow-up of tuberculosis patients undergoing standard anti-tuberculosis chemotherapy by using a polymerase chain reaction. Res Microbiol 1994; 145: 5-8.
6. Yuen KY, Chan KS, Chan CM et al. Use of PCR in routine diagnosis of treated and untreated pulmonary tuberculosis. J Clin Pathol 1993; 46: 318-322.
7. Hong Kong Chest Service/Tubercolosis Research Centre, Madras/ British Medical Research Council. A study of the characteristics and course of sputum smear-negative pulmonary tuberculosis. Tubercle 1981; 62: 155-167.
8. Singapore Tuberculosis Service/British Medical Research Council: Long term follow-up of a clinical trial of six-month and four month regimens of chemotherapy in the treatment of pulmonary tuberculosis. Am Rev Respir Dis 1986; 133: 779-783.
9. Goble M, Iseman MD, Madsen LA, White D, Ackerson L, JR RH. Treatment of 171 patients with pulmonary tuberculosis resistant to isoniazid and rifampicin. N Engl J Med 1993; 328: 527-532.
10. Bengard Andersen A, Hansen EB. Structure and mapping of antigenic domains of protein antigen b, a 38,000-molecular weight protein of Mycobacterium tuberculosis. Infect Immun 1989; 57: 2481-2488.
11. Thierry D, Caves MD, Eisenach KD et al. IS6110, an IS-like element of M. tuberculosis complex. Nucleic Acid Res 1989; 18: 188.
12. Kwok S, Higuichi R. Avoiding false positives with PCR. Nature 1989; 339: 237-238.
13. Walker DA, Taylor IK, Mitchell DM, Shaw RJ. Comparison of polymerase chain reaction amplification of two mycobacterial DNA sequences, IS6110 and the 65 kDa antigen gene, in the diagnosis of tuberculosis. Thorax 1992; 47: 690-694.
14. Stanford JL. Mych's granules revisited. Tubercle 1987; 68: 241-242.
15. Hong Kong Chest Service/Tuberculosis Research Centre Madras/ British Medical Research Council. A controlled trials of 3 month, 4 month, and 6 month regimens of chemotherapy for sputum-smear-negative pulmonary tuberculosis: results at 5 years. Ann Rev Respir Dis 1989; 139: 871-876.